Cyanate-mediated inhibition of neutrophil myeloperoxidase activity

被引:21
|
作者
Qian, MW
Eaton, JW
Wolff, SP
机构
[1] BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA
[2] ALBANY MED COLL, DEPT PHYSIOL & CELL BIOL, ALBANY, NY 12208 USA
[3] UCL, DEPT CLIN PHARMACOL, LONDON, ENGLAND
关键词
D O I
10.1042/bj3260159
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyanate (CNO-) forms spontaneously in solutions containing urea, and is present in urine and the body fluids of uraemic patients, We have explored the possibility that CNO- might be one of the unknown substances responsible for the reported impairment, by urine and uraemic plasma, of neutrophil oxidative metabolism (especially as measured by luminol-enhanced chemiluminescence). Luminol-enhanced chemiluminescence generated by human neutrophils derives predominantly from the activity of myeloperoxidase (MPG) which produces hypochlorous acid from H2O2 and Cl-. We hypothesized that CNO- (which resembles the 'pseudohalide' thiocyanate, an alternative substrate for MPO) might somehow interfere with the activity of MPO. In support of this, we find: (i) CNO- inhibits both peroxidative and halogenating activities of MPO and also inhibits the enzyme within intact human neutrophils; (ii) the inhibition is H2O2-dependent, irreversible, accompanied by covalent addition of [C-14]CNO- (or a carbon-containing fragment thereof) to the enzyme; (iii) CNO- also inhibits Cl-/H2O2/MPO-mediated bacterial killing. Impairment of this arm of neutrophil bactericidal activity by CNO- formed from urea may be one factor in the risk of urinary-tract infection associated with urinary stasis and perhaps in the generalized increase in susceptibility to infection in uraemic patients.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 50 条
  • [21] NEUTROPHIL MYELOPEROXIDASE - SIMPLE, REPRODUCIBLE TECHNIQUE TO DETERMINE ACTIVITY
    KITAHARA, M
    SIMONIAN, Y
    EYRE, HJ
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1979, 93 (02): : 232 - 237
  • [22] Neutrophil dysfunction induced by hyperglycemia: modulation of myeloperoxidase activity
    Ferreira, Claudia de Souza
    Araujo, Tomaz Henrique
    Angelo, Marilene Lopes
    Pennacchi, Paula Commune
    Okada, Sabrina Sayori
    de Araujo Paula, Fernanda Borges
    Migliorini, Silene
    Rodrigues, Maria Rita
    CELL BIOCHEMISTRY AND FUNCTION, 2012, 30 (07) : 604 - 610
  • [23] Neutrophil myeloperoxidase activity in hematologic malignancies at diagnosis.
    Zini, G
    Giordano, G
    Mistretta, G
    d'Onofrio, G
    BLOOD, 2002, 100 (11) : 37B - 37B
  • [24] NEUTROPHIL COUNT AND MYELOPEROXIDASE ACTIVITY IN INDIAN BIDI SMOKERS
    BEHERA, D
    DASH, S
    SEN, S
    RESPIRATION, 1994, 61 (05) : 269 - 273
  • [25] INTERACTION OF MYELOPEROXIDASE WITH DICLOFENAC - INHIBITION OF THE CHLORINATING ACTIVITY OF MYELOPEROXIDASE BY DICLOFENAC AND OXIDATION OF DICLOFENAC TO DIHYDROXYAZOBENZENE BY MYELOPEROXIDASE
    ZUURBIER, KWM
    BAKKENIST, ARJ
    FOKKENS, RH
    NIBBERING, NMM
    WEVER, R
    MUIJSERS, AO
    BIOCHEMICAL PHARMACOLOGY, 1990, 40 (08) : 1801 - 1808
  • [26] Inhibition of Myeloperoxidase- and Neutrophil-Mediated Hypochlorous Acid Formation in Vitro and Endothelial Cell Injury by (-)-Epigallocatechin Gallate
    Tian, Rong
    Ding, Yun
    Peng, Yi-Yuan
    Lu, Naihao
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2017, 65 (15) : 3198 - 3203
  • [27] INHIBITION OF THE IL-8 INDUCED NEUTROPHIL CHEMOTACTIC RESPONSE BY MYELOPEROXIDASE
    DHAMI, D
    SHUTE, J
    CHURCH, MK
    CLINICAL AND EXPERIMENTAL ALLERGY, 1994, 24 (02): : 179 - 179
  • [28] Inhibition of Myeloperoxidase-Mediated Endothelial Dysfunction by Nitroxides
    Maiocchi, Sophie
    Dang, Lei
    Morris, Jonathan
    Thomas, Shane
    Rees, Martin
    FREE RADICAL BIOLOGY AND MEDICINE, 2015, 86 : S28 - S29
  • [29] NEUTROPHIL-PLATELET INTERACTION MEDIATED BY MYELOPEROXIDASE AND HYDROGEN-PEROXIDE
    CLARK, RA
    KLEBANOFF, SJ
    JOURNAL OF IMMUNOLOGY, 1980, 124 (01): : 399 - 405
  • [30] NEUTROPHIL INACTIVATION OF PNEUMOCOCCAL TOXIN MEDIATED BY MYELOPEROXIDASE AND HYDROGEN-PEROXIDE
    CLARK, RA
    CLINICAL RESEARCH, 1982, 30 (02): : A517 - A517